On Feb. 20, 2026, the United States Court of Appeals for the Federal Circuit (“Federal Circuit”) issued a thoughtful analysis of biotechnology subject-matter eligibility in REGENXBIO, Inc. v. […]
AI and Corporate Compliance: Best Practices for Addressing the DOJ’s Expectations for AI Risk Management | Haynes Boone
In September 2024, the Criminal Division of the Department of Justice (DOJ) issued a significant update to its Evaluation of Corporate Compliance Programs (ECCP) policy document, introducing detailed […]
When “Skin in the Game” Meets Uninsurable Risk: Rethinking “Knock-for-Knock” Carve Outs | Haynes Boone
In the offshore oil and gas sector, procurement contracts have long served as sophisticated risk management tools designed to promote commercial certainty by clearly defining parties’ obligations and […]
The FDA Opens a Wider Door for Wellness Wearables | Haynes Boone
As Americans kick off the new year with resolutions to get fit, sleep better, and take better care of themselves, the FDA has broadened access to the wearable […]